Dafna Capital Management LLC Edgewise Therapeutics, Inc. Transaction History
Dafna Capital Management LLC
- $331 Million
- Q1 2025
A detailed history of Dafna Capital Management LLC transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Dafna Capital Management LLC holds 183,140 shares of EWTX stock, worth $2.61 Million. This represents 1.22% of its overall portfolio holdings.
Number of Shares
183,140
Previous 187,140
2.14%
Holding current value
$2.61 Million
Previous $5 Million
19.36%
% of portfolio
1.22%
Previous 1.36%
Shares
12 transactions
Others Institutions Holding EWTX
# of Institutions
222Shares Held
105MCall Options Held
2.57MPut Options Held
1.58M-
Orbimed Advisors LLC San Diego, CA15MShares$214 Million10.3% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$127 Million4.07% of portfolio
-
Perceptive Advisors LLC New York, NY6.55MShares$93.4 Million6.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6.16MShares$87.8 Million1.61% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$85.8 Million0.0% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $901M
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...